- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
The Immunology Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest study, due to COVID-19 pandemic, the global Immunology Drug market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospitals accounting for % of the Immunology Drug global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Monoclonal Antibodies (mAb) segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Immunology Drug include Abbott Laboratories, Active Biotech, Eli Lilly and Company, Autoimmune Inc., and Pfizer, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Immunology Drug market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Monoclonal Antibodies (mAb)
Antibody Drug Conjugates
Immunosuppressive medication
Others
Market segment by Application can be divided into
Hospitals
Clinics
Cancer Research Centers and Institutes
The key market players for global Immunology Drug market are listed below:
Abbott Laboratories
Active Biotech
Eli Lilly and Company
Autoimmune Inc.
Pfizer
GlaxoSmithKline plc
Seattle Genetics
Genentech
F. Hoffmann-La Roche Ltd.
Eisai Co.
Bayer AG
Sanofi Aventis LLC.
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Immunology Drug product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Immunology Drug, with price, sales, revenue and global market share of Immunology Drug from 2019 to 2022.
Chapter 3, the Immunology Drug competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Immunology Drug breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Immunology Drug market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Immunology Drug.
Chapter 13, 14, and 15, to describe Immunology Drug sales channel, distributors, customers, research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1 Market Overview
1.1 Immunology Drug Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Immunology Drug Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Monoclonal Antibodies (mAb)
1.2.3 Antibody Drug Conjugates
1.2.4 Immunosuppressive medication
1.2.5 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Immunology Drug Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Cancer Research Centers and Institutes
1.4 Global Immunology Drug Market Size & Forecast
1.4.1 Global Immunology Drug Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Immunology Drug Sales in Volume (2017-2028)
1.4.3 Global Immunology Drug Price (2017-2028)
1.5 Global Immunology Drug Production Capacity Analysis
1.5.1 Global Immunology Drug Total Production Capacity (2017-2028)
1.5.2 Global Immunology Drug Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Immunology Drug Market Drivers
1.6.2 Immunology Drug Market Restraints
1.6.3 Immunology Drug Trends Analysis
2 Manufacturers Profiles
2 Manufacturers Profiles
2.1 Abbott Laboratories
2.1.1 Abbott Laboratories Details
2.1.2 Abbott Laboratories Major Business
2.1.3 Abbott Laboratories Immunology Drug Product and Services
2.1.4 Abbott Laboratories Immunology Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Active Biotech
2.2.1 Active Biotech Details
2.2.2 Active Biotech Major Business
2.2.3 Active Biotech Immunology Drug Product and Services
2.2.4 Active Biotech Immunology Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Eli Lilly and Company
2.3.1 Eli Lilly and Company Details
2.3.2 Eli Lilly and Company Major Business
2.3.3 Eli Lilly and Company Immunology Drug Product and Services
2.3.4 Eli Lilly and Company Immunology Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Autoimmune Inc.
2.4.1 Autoimmune Inc. Details
2.4.2 Autoimmune Inc. Major Business
2.4.3 Autoimmune Inc. Immunology Drug Product and Services
2.4.4 Autoimmune Inc. Immunology Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Pfizer
2.5.1 Pfizer Details
2.5.2 Pfizer Major Business
2.5.3 Pfizer Immunology Drug Product and Services
2.5.4 Pfizer Immunology Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 GlaxoSmithKline plc
2.6.1 GlaxoSmithKline plc Details
2.6.2 GlaxoSmithKline plc Major Business
2.6.3 GlaxoSmithKline plc Immunology Drug Product and Services
2.6.4 GlaxoSmithKline plc Immunology Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Seattle Genetics
2.7.1 Seattle Genetics Details
2.7.2 Seattle Genetics Major Business
2.7.3 Seattle Genetics Immunology Drug Product and Services
2.7.4 Seattle Genetics Immunology Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Genentech
2.8.1 Genentech Details
2.8.2 Genentech Major Business
2.8.3 Genentech Immunology Drug Product and Services
2.8.4 Genentech Immunology Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 F. Hoffmann-La Roche Ltd.
2.9.1 F. Hoffmann-La Roche Ltd. Details
2.9.2 F. Hoffmann-La Roche Ltd. Major Business
2.9.3 F. Hoffmann-La Roche Ltd. Immunology Drug Product and Services
2.9.4 F. Hoffmann-La Roche Ltd. Immunology Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Eisai Co.
2.10.1 Eisai Co. Details
2.10.2 Eisai Co. Major Business
2.10.3 Eisai Co. Immunology Drug Product and Services
2.10.4 Eisai Co. Immunology Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Bayer AG
2.11.1 Bayer AG Details
2.11.2 Bayer AG Major Business
2.11.3 Bayer AG Immunology Drug Product and Services
2.11.4 Bayer AG Immunology Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Sanofi Aventis LLC.
2.12.1 Sanofi Aventis LLC. Details
2.12.2 Sanofi Aventis LLC. Major Business
2.12.3 Sanofi Aventis LLC. Immunology Drug Product and Services
2.12.4 Sanofi Aventis LLC. Immunology Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Immunology Drug Breakdown Data by Manufacturer
3 Immunology Drug Breakdown Data by Manufacturer
3.1 Global Immunology Drug Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Immunology Drug Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Immunology Drug
3.4 Market Concentration Rate
3.4.1 Top 3 Immunology Drug Manufacturer Market Share in 2021
3.4.2 Top 6 Immunology Drug Manufacturer Market Share in 2021
3.5 Global Immunology Drug Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Immunology Drug Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4 Market Analysis by Region
4.1 Global Immunology Drug Market Size by Region
4.1.1 Global Immunology Drug Sales in Volume by Region (2017-2028)
4.1.2 Global Immunology Drug Revenue by Region (2017-2028)
4.2 North America Immunology Drug Revenue (2017-2028)
4.3 Europe Immunology Drug Revenue (2017-2028)
4.4 Asia-Pacific Immunology Drug Revenue (2017-2028)
4.5 South America Immunology Drug Revenue (2017-2028)
4.6 Middle East and Africa Immunology Drug Revenue (2017-2028)
5 Market Segment by Type
5 Market Segment by Type
5.1 Global Immunology Drug Sales in Volume by Type (2017-2028)
5.2 Global Immunology Drug Revenue by Type (2017-2028)
5.3 Global Immunology Drug Price by Type (2017-2028)
6 Market Segment by Application
6 Market Segment by Application
6.1 Global Immunology Drug Sales in Volume by Application (2017-2028)
6.2 Global Immunology Drug Revenue by Application (2017-2028)
6.3 Global Immunology Drug Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7 North America by Country, by Type, and by Application
7.1 North America Immunology Drug Sales by Type (2017-2028)
7.2 North America Immunology Drug Sales by Application (2017-2028)
7.3 North America Immunology Drug Market Size by Country
7.3.1 North America Immunology Drug Sales in Volume by Country (2017-2028)
7.3.2 North America Immunology Drug Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8 Europe by Country, by Type, and by Application
8.1 Europe Immunology Drug Sales by Type (2017-2028)
8.2 Europe Immunology Drug Sales by Application (2017-2028)
8.3 Europe Immunology Drug Market Size by Country
8.3.1 Europe Immunology Drug Sales in Volume by Country (2017-2028)
8.3.2 Europe Immunology Drug Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Immunology Drug Sales by Type (2017-2028)
9.2 Asia-Pacific Immunology Drug Sales by Application (2017-2028)
9.3 Asia-Pacific Immunology Drug Market Size by Region
9.3.1 Asia-Pacific Immunology Drug Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Immunology Drug Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10 South America by Region, by Type, and by Application
10.1 South America Immunology Drug Sales by Type (2017-2028)
10.2 South America Immunology Drug Sales by Application (2017-2028)
10.3 South America Immunology Drug Market Size by Country
10.3.1 South America Immunology Drug Sales in Volume by Country (2017-2028)
10.3.2 South America Immunology Drug Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Immunology Drug Sales by Type (2017-2028)
11.2 Middle East & Africa Immunology Drug Sales by Application (2017-2028)
11.3 Middle East & Africa Immunology Drug Market Size by Country
11.3.1 Middle East & Africa Immunology Drug Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Immunology Drug Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12 Raw Material and Industry Chain
12.1 Raw Material of Immunology Drug and Key Manufacturers
12.2 Manufacturing Costs Percentage of Immunology Drug
12.3 Immunology Drug Production Process
12.4 Immunology Drug Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Immunology Drug Typical Distributors
13.3 Immunology Drug Typical Customers
14 Research Findings and Conclusion
14 Research Findings and Conclusion
15 Appendix
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
List of Tables
Table 1. Global Immunology Drug Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Immunology Drug Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Abbott Laboratories Basic Information, Manufacturing Base and Competitors
Table 4. Abbott Laboratories Major Business
Table 5. Abbott Laboratories Immunology Drug Product and Services
Table 6. Abbott Laboratories Immunology Drug Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Active Biotech Basic Information, Manufacturing Base and Competitors
Table 8. Active Biotech Major Business
Table 9. Active Biotech Immunology Drug Product and Services
Table 10. Active Biotech Immunology Drug Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Eli Lilly and Company Basic Information, Manufacturing Base and Competitors
Table 12. Eli Lilly and Company Major Business
Table 13. Eli Lilly and Company Immunology Drug Product and Services
Table 14. Eli Lilly and Company Immunology Drug Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Autoimmune Inc. Basic Information, Manufacturing Base and Competitors
Table 16. Autoimmune Inc. Major Business
Table 17. Autoimmune Inc. Immunology Drug Product and Services
Table 18. Autoimmune Inc. Immunology Drug Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Pfizer Basic Information, Manufacturing Base and Competitors
Table 20. Pfizer Major Business
Table 21. Pfizer Immunology Drug Product and Services
Table 22. Pfizer Immunology Drug Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. GlaxoSmithKline plc Basic Information, Manufacturing Base and Competitors
Table 24. GlaxoSmithKline plc Major Business
Table 25. GlaxoSmithKline plc Immunology Drug Product and Services
Table 26. GlaxoSmithKline plc Immunology Drug Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Seattle Genetics Basic Information, Manufacturing Base and Competitors
Table 28. Seattle Genetics Major Business
Table 29. Seattle Genetics Immunology Drug Product and Services
Table 30. Seattle Genetics Immunology Drug Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Genentech Basic Information, Manufacturing Base and Competitors
Table 32. Genentech Major Business
Table 33. Genentech Immunology Drug Product and Services
Table 34. Genentech Immunology Drug Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. F. Hoffmann-La Roche Ltd. Basic Information, Manufacturing Base and Competitors
Table 36. F. Hoffmann-La Roche Ltd. Major Business
Table 37. F. Hoffmann-La Roche Ltd. Immunology Drug Product and Services
Table 38. F. Hoffmann-La Roche Ltd. Immunology Drug Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Eisai Co. Basic Information, Manufacturing Base and Competitors
Table 40. Eisai Co. Major Business
Table 41. Eisai Co. Immunology Drug Product and Services
Table 42. Eisai Co. Immunology Drug Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Bayer AG Basic Information, Manufacturing Base and Competitors
Table 44. Bayer AG Major Business
Table 45. Bayer AG Immunology Drug Product and Services
Table 46. Bayer AG Immunology Drug Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. Sanofi Aventis LLC. Basic Information, Manufacturing Base and Competitors
Table 48. Sanofi Aventis LLC. Major Business
Table 49. Sanofi Aventis LLC. Immunology Drug Product and Services
Table 50. Sanofi Aventis LLC. Immunology Drug Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 51. Global Immunology Drug Sales by Manufacturer (2019, 2020, 2021, and 2022) & (MT)
Table 52. Global Immunology Drug Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 53. Market Position of Manufacturers in Immunology Drug, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 54. Global Immunology Drug Production Capacity by Company, (MT): 2020 VS 2021
Table 55. Head Office and Immunology Drug Production Site of Key Manufacturer
Table 56. Immunology Drug New Entrant and Capacity Expansion Plans
Table 57. Immunology Drug Mergers & Acquisitions in the Past Five Years
Table 58. Global Immunology Drug Sales by Region (2017-2022) & (MT)
Table 59. Global Immunology Drug Sales by Region (2023-2028) & (MT)
Table 60. Global Immunology Drug Revenue by Region (2017-2022) & (USD Million)
Table 61. Global Immunology Drug Revenue by Region (2023-2028) & (USD Million)
Table 62. Global Immunology Drug Sales by Type (2017-2022) & (MT)
Table 63. Global Immunology Drug Sales by Type (2023-2028) & (MT)
Table 64. Global Immunology Drug Revenue by Type (2017-2022) & (USD Million)
Table 65. Global Immunology Drug Revenue by Type (2023-2028) & (USD Million)
Table 66. Global Immunology Drug Price by Type (2017-2022) & (USD/Kg)
Table 67. Global Immunology Drug Price by Type (2023-2028) & (USD/Kg)
Table 68. Global Immunology Drug Sales by Application (2017-2022) & (MT)
Table 69. Global Immunology Drug Sales by Application (2023-2028) & (MT)
Table 70. Global Immunology Drug Revenue by Application (2017-2022) & (USD Million)
Table 71. Global Immunology Drug Revenue by Application (2023-2028) & (USD Million)
Table 72. Global Immunology Drug Price by Application (2017-2022) & (USD/Kg)
Table 73. Global Immunology Drug Price by Application (2023-2028) & (USD/Kg)
Table 74. North America Immunology Drug Sales by Country (2017-2022) & (MT)
Table 75. North America Immunology Drug Sales by Country (2023-2028) & (MT)
Table 76. North America Immunology Drug Revenue by Country (2017-2022) & (USD Million)
Table 77. North America Immunology Drug Revenue by Country (2023-2028) & (USD Million)
Table 78. North America Immunology Drug Sales by Type (2017-2022) & (MT)
Table 79. North America Immunology Drug Sales by Type (2023-2028) & (MT)
Table 80. North America Immunology Drug Sales by Application (2017-2022) & (MT)
Table 81. North America Immunology Drug Sales by Application (2023-2028) & (MT)
Table 82. Europe Immunology Drug Sales by Country (2017-2022) & (MT)
Table 83. Europe Immunology Drug Sales by Country (2023-2028) & (MT)
Table 84. Europe Immunology Drug Revenue by Country (2017-2022) & (USD Million)
Table 85. Europe Immunology Drug Revenue by Country (2023-2028) & (USD Million)
Table 86. Europe Immunology Drug Sales by Type (2017-2022) & (MT)
Table 87. Europe Immunology Drug Sales by Type (2023-2028) & (MT)
Table 88. Europe Immunology Drug Sales by Application (2017-2022) & (MT)
Table 89. Europe Immunology Drug Sales by Application (2023-2028) & (MT)
Table 90. Asia-Pacific Immunology Drug Sales by Region (2017-2022) & (MT)
Table 91. Asia-Pacific Immunology Drug Sales by Region (2023-2028) & (MT)
Table 92. Asia-Pacific Immunology Drug Revenue by Region (2017-2022) & (USD Million)
Table 93. Asia-Pacific Immunology Drug Revenue by Region (2023-2028) & (USD Million)
Table 94. Asia-Pacific Immunology Drug Sales by Type (2017-2022) & (MT)
Table 95. Asia-Pacific Immunology Drug Sales by Type (2023-2028) & (MT)
Table 96. Asia-Pacific Immunology Drug Sales by Application (2017-2022) & (MT)
Table 97. Asia-Pacific Immunology Drug Sales by Application (2023-2028) & (MT)
Table 98. South America Immunology Drug Sales by Country (2017-2022) & (MT)
Table 99. South America Immunology Drug Sales by Country (2023-2028) & (MT)
Table 100. South America Immunology Drug Revenue by Country (2017-2022) & (USD Million)
Table 101. South America Immunology Drug Revenue by Country (2023-2028) & (USD Million)
Table 102. South America Immunology Drug Sales by Type (2017-2022) & (MT)
Table 103. South America Immunology Drug Sales by Type (2023-2028) & (MT)
Table 104. South America Immunology Drug Sales by Application (2017-2022) & (MT)
Table 105. South America Immunology Drug Sales by Application (2023-2028) & (MT)
Table 106. Middle East & Africa Immunology Drug Sales by Region (2017-2022) & (MT)
Table 107. Middle East & Africa Immunology Drug Sales by Region (2023-2028) & (MT)
Table 108. Middle East & Africa Immunology Drug Revenue by Region (2017-2022) & (USD Million)
Table 109. Middle East & Africa Immunology Drug Revenue by Region (2023-2028) & (USD Million)
Table 110. Middle East & Africa Immunology Drug Sales by Type (2017-2022) & (MT)
Table 111. Middle East & Africa Immunology Drug Sales by Type (2023-2028) & (MT)
Table 112. Middle East & Africa Immunology Drug Sales by Application (2017-2022) & (MT)
Table 113. Middle East & Africa Immunology Drug Sales by Application (2023-2028) & (MT)
Table 114. Immunology Drug Raw Material
Table 115. Key Manufacturers of Immunology Drug Raw Materials
Table 116. Direct Channel Pros & Cons
Table 117. Indirect Channel Pros & Cons
Table 118. Immunology Drug Typical Distributors
Table 119. Immunology Drug Typical Customers
List of Figures
Figure 1. Immunology Drug Picture
Figure 2. Global Immunology Drug Revenue Market Share by Type in 2021
Figure 3. Monoclonal Antibodies (mAb)
Figure 4. Antibody Drug Conjugates
Figure 5. Immunosuppressive medication
Figure 6. Others
Figure 7. Global Immunology Drug Revenue Market Share by Application in 2021
Figure 8. Hospitals
Figure 9. Clinics
Figure 10. Cancer Research Centers and Institutes
Figure 11. Global Immunology Drug Revenue, (USD Million) & (MT): 2017 & 2021 & 2028
Figure 12. Global Immunology Drug Revenue and Forecast (2017-2028) & (USD Million)
Figure 13. Global Immunology Drug Sales (2017-2028) & (MT)
Figure 14. Global Immunology Drug Price (2017-2028) & (USD/Kg)
Figure 15. Global Immunology Drug Production Capacity (2017-2028) & (MT)
Figure 16. Global Immunology Drug Production Capacity by Geographic Region: 2022 VS 2028
Figure 17. Immunology Drug Market Drivers
Figure 18. Immunology Drug Market Restraints
Figure 19. Immunology Drug Market Trends
Figure 20. Global Immunology Drug Sales Market Share by Manufacturer in 2021
Figure 21. Global Immunology Drug Revenue Market Share by Manufacturer in 2021
Figure 22. Immunology Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 23. Top 3 Immunology Drug Manufacturer (Revenue) Market Share in 2021
Figure 24. Top 6 Immunology Drug Manufacturer (Revenue) Market Share in 2021
Figure 25. Global Immunology Drug Sales Market Share by Region (2017-2028)
Figure 26. Global Immunology Drug Revenue Market Share by Region (2017-2028)
Figure 27. North America Immunology Drug Revenue (2017-2028) & (USD Million)
Figure 28. Europe Immunology Drug Revenue (2017-2028) & (USD Million)
Figure 29. Asia-Pacific Immunology Drug Revenue (2017-2028) & (USD Million)
Figure 30. South America Immunology Drug Revenue (2017-2028) & (USD Million)
Figure 31. Middle East & Africa Immunology Drug Revenue (2017-2028) & (USD Million)
Figure 32. Global Immunology Drug Sales Market Share by Type (2017-2028)
Figure 33. Global Immunology Drug Revenue Market Share by Type (2017-2028)
Figure 34. Global Immunology Drug Price by Type (2017-2028) & (USD/Kg)
Figure 35. Global Immunology Drug Sales Market Share by Application (2017-2028)
Figure 36. Global Immunology Drug Revenue Market Share by Application (2017-2028)
Figure 37. Global Immunology Drug Price by Application (2017-2028) & (USD/Kg)
Figure 38. North America Immunology Drug Sales Market Share by Type (2017-2028)
Figure 39. North America Immunology Drug Sales Market Share by Application (2017-2028)
Figure 40. North America Immunology Drug Sales Market Share by Country (2017-2028)
Figure 41. North America Immunology Drug Revenue Market Share by Country (2017-2028)
Figure 42. United States Immunology Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Canada Immunology Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Mexico Immunology Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Europe Immunology Drug Sales Market Share by Type (2017-2028)
Figure 46. Europe Immunology Drug Sales Market Share by Application (2017-2028)
Figure 47. Europe Immunology Drug Sales Market Share by Country (2017-2028)
Figure 48. Europe Immunology Drug Revenue Market Share by Country (2017-2028)
Figure 49. Germany Immunology Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. France Immunology Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. United Kingdom Immunology Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Russia Immunology Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Italy Immunology Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Asia-Pacific Immunology Drug Sales Market Share by Region (2017-2028)
Figure 55. Asia-Pacific Immunology Drug Sales Market Share by Application (2017-2028)
Figure 56. Asia-Pacific Immunology Drug Sales Market Share by Region (2017-2028)
Figure 57. Asia-Pacific Immunology Drug Revenue Market Share by Region (2017-2028)
Figure 58. China Immunology Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Japan Immunology Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Korea Immunology Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. India Immunology Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Southeast Asia Immunology Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Australia Immunology Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. South America Immunology Drug Sales Market Share by Type (2017-2028)
Figure 65. South America Immunology Drug Sales Market Share by Application (2017-2028)
Figure 66. South America Immunology Drug Sales Market Share by Country (2017-2028)
Figure 67. South America Immunology Drug Revenue Market Share by Country (2017-2028)
Figure 68. Brazil Immunology Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Argentina Immunology Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Middle East & Africa Immunology Drug Sales Market Share by Type (2017-2028)
Figure 71. Middle East & Africa Immunology Drug Sales Market Share by Application (2017-2028)
Figure 72. Middle East & Africa Immunology Drug Sales Market Share by Region (2017-2028)
Figure 73. Middle East & Africa Immunology Drug Revenue Market Share by Region (2017-2028)
Figure 74. Turkey Immunology Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Egypt Immunology Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Saudi Arabia Immunology Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. South Africa Immunology Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. Manufacturing Cost Structure Analysis of Immunology Drug in 2021
Figure 79. Manufacturing Process Analysis of Immunology Drug
Figure 80. Immunology Drug Industrial Chain
Figure 81. Sales Channel: Direct Channel vs Indirect Channel
Figure 82. Methodology
Figure 83. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
